Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial
American Journal of Nephrology · 2025
DOI: 10.1159/000547121 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Fozia Z Ahmed und 18 weiteren Autor:innen. Beteiligte Einrichtung: Keele University, Keele Cardiovascular Research Group, Keele, UK. Hauptthemen laut MEDLINE: Heart Failure, Ferric Compounds, Anemia, Iron-Deficiency, Maltose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: British Heart Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Introduction
For heart failure (HF) with iron deficiency (ID), the benefits of intravenous iron might differ according to kidney function.
Methods
IRONMAN was a randomised, open-label trial of intravenous ferric derisomaltose (FDI) versus usual care (UC) in patients with HF, left ventricular ejection fraction ≤45%, and ID (transferrin saturation
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Keele University, Keele Cardiovascular Research Group, Keele, UK.
- Department of Cardiology, Manchester University NHS Foundation Trust, Manchester, UK.
- School of Cardiovascular and Metabolic Health, University of Glasgow, British Heart Foundation Cardiovascular Research Centre, Glasgow, UK.
- University of Sheffield, Department of Infection, Immunity and Cardiovascular Disease, Sheffield, UK.
- Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
- Department of Cardiology, University Hospital Crosshouse, Kilmarnock, UK.
Förderung
- British Heart Foundation
Zitieren
APA
Ahmed, F. Z., Kalra, P. R., Cleland, J. G. F., Al-Mohammad, A., Clark, A. L., Chong, V. K. S., Japp, A. G., Lane, R. E., Leslie, S. J., Macdougall, I. C., Nageh, T., Sankaranarayanan, R., Sobolewska, J., Wong, A., Thomson, E. A., Petrie, M. C., Squire, I. B., Ford, I., & Kalra, P. A. (2025). Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial. American Journal of Nephrology. https://doi.org/10.1159/000547121
Vancouver
Ahmed FZ, Kalra PR, Cleland JGF, Al-Mohammad A, Clark AL, Chong VKS, et al. Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial. American Journal of Nephrology. 2025. doi:10.1159/000547121
BibTeX
@article{Ahmed2025,
author = {Ahmed, Fozia Z and Kalra, Paul R and Cleland, John G F and Al-Mohammad, Abdallah and Clark, Andrew L and Chong, Victor K S and Japp, Alan G and Lane, Rebecca E and Leslie, Stephen J and Macdougall, Iain C and Nageh, Thuraia and Sankaranarayanan, Rajiv and Sobolewska, Jolanta and Wong, Aaron and Thomson, Elizabeth A and Petrie, Mark C and Squire, Iain B and Ford, Ian and Kalra, Philip A},
title = {Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial},
journal = {American Journal of Nephrology},
year = {2025},
doi = {10.1159/000547121}
}
EUVIMED